CORE PHARMACEUTICALS LIMITED
Significant control: Sharief Group Limited (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Core Pharmaceuticals Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Core Pharmaceuticals Limited sell?
Registered activity: Wholesale of pharmaceutical goods (SIC 46460). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
CORE PHARMACEUTICALS LIMITED is an active private limited company (company number 12792227) incorporated on 4 August 2020, registered in St Helens. Its registered activity is wholesale of pharmaceutical goods (SIC 46460). Latest small accounts cover the period ending 31 July 2024, showing net assets of −£66k and cash of £3,923, with 2 employees on average. Net assets fell 335% on the prior period (−£15k).
By net assets it sits in the bottom quarter of 102 comparable companies in Manchester (median £8,731, upper quartile £180k).
Ownership and control
- Sharief Group Limited
- owns 75–100% of shares
- Mrs Khadija Sami
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 4 August 20206 yrs ago
- Next accounts due
- 30 April 2026178 days overdue
- Confirmation statement due
- 18 August 2027in 297 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 46460
- Wholesale of pharmaceutical goods
- Accounts type
- Audit Exemption Subsidiary
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 July 2024 | −£66k | £3,923 | £128k | — | — | — | 2 |
| 31 August 2023 | −£15k | £4,068 | £1,443 | — | — | — | 1 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets below zeroNet assets £-65,886 at 31 July 2024
- Net assets down 25% or more on the prior period-334.6% vs prior period
- Incorporated five or more years agoIncorporated 4 August 2020
- Accounts past their due dateDue 30 April 2026
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 297 days
- Next accounts due178 days overdue
- Accounts period endNet liabilities £66k · small accounts
- Accounts period endNet liabilities £15k · small accounts
- Incorporated
Similar companies in Manchester
- JEST NW LTDKnutsford · inc. Jul 2020
- MALGORZATA SUCHY LIMITEDWarrington · inc. Jun 2020
- HA PHARMA CONSULTANCY LIMITEDManchester · inc. Apr 2020
- SPECTRUMX MEDICAL LIMITEDKnutsford · inc. Nov 2020
- VIRAGUARD LIMITEDStockport · inc. Apr 2020
- MEDNORTH LTDBolton · inc. Mar 2020
All companies incorporated on 4 August 2020 · in Aug 2020.
Reminders for CORE PHARMACEUTICALS LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.